Safety and immunogenicity of the third and fourth doses of vaccine against SARS-CoV-2 following a 2-dose regimen of inactivated whole-virion SARS-CoV-2 vaccine.
Chaiwarith R, Winichakoon P, Salee P, Sudjaritruk T, Wipasa J, Chawansuntati K, Yasri S, Thongwitokomarn H, Krasaewes K, Ruangsirinusorn S, Praparattanapan J, Solai N, Nuket K, Boonmee D, Chaichana O, Mueangmo O, Saheng J, Wongjak W.
Chaiwarith R, et al. Among authors: thongwitokomarn h.
Sci Rep. 2023 Nov 13;13(1):19736. doi: 10.1038/s41598-023-45735-7.
Sci Rep. 2023.
PMID: 37957189
Free PMC article.